CALCA and migraine disorder: Fortunately, the CGRP monoclonal antibodies used clinically for migraine are thought to have little effect on the immune system.10 In addition, a small tracking study following individuals with chronic migraine and MS who use CGRP inhibitors has not detected any worsening of MS symptoms.15